Suvizumab
Suvizumab is an antiviral and immunomodulator. It binds to HIV-1.[1]
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized |
| Target | HIV-1 |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
  | |
References
- "Proposed List number 102 of International Nonproprietary Names" (PDF). WHO Drug Information. Geneva: World Health Organization. 23 (4): 344. 2009. ISSN 1010-9609.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.